Adicet Bio, Inc. (FRA:1IJA)
Germany
· Delayed Price · Currency is EUR 0.4108
-0.0202 (-4.69%)
At close: Dec 4, 2025
Adicet Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | - | - | - | 24.99 | 9.73 | 17.9 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | 156.83% | -45.65% | 1699.30% | Upgrade
|
| Gross Profit | - | - | - | 24.99 | 9.73 | 17.9 | Upgrade
|
| Selling, General & Admin | 23.61 | 28.29 | 26.53 | 26.3 | 22.22 | 15.66 | Upgrade
|
| Research & Development | 97.36 | 99.32 | 106.04 | 71.25 | 47.75 | 33.93 | Upgrade
|
| Operating Expenses | 120.97 | 127.62 | 132.58 | 97.54 | 69.97 | 49.59 | Upgrade
|
| Operating Income | -120.97 | -127.62 | -132.58 | -72.55 | -60.24 | -31.69 | Upgrade
|
| Interest Expense | -0.01 | -0 | -0.03 | -0.08 | -0.18 | -0.13 | Upgrade
|
| Interest & Investment Income | 6.32 | 10.71 | 9.98 | 3.76 | 0.09 | 0.79 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.35 | -0.22 | -0.57 | -0.92 | -0.61 | -0.95 | Upgrade
|
| EBT Excluding Unusual Items | -115.01 | -117.12 | -123.2 | -69.79 | -60.93 | -31.99 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -7.1 | Upgrade
|
| Impairment of Goodwill | - | - | -19.46 | - | - | - | Upgrade
|
| Asset Writedown | - | - | - | - | -1.19 | -2.3 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 1.9 | Upgrade
|
| Pretax Income | -115.01 | -117.12 | -142.66 | -69.79 | -62.12 | -39.49 | Upgrade
|
| Income Tax Expense | - | - | - | - | -0.13 | -2.82 | Upgrade
|
| Net Income | -115.01 | -117.12 | -142.66 | -69.79 | -62 | -36.68 | Upgrade
|
| Net Income to Common | -115.01 | -117.12 | -142.66 | -69.79 | -62 | -36.68 | Upgrade
|
| Shares Outstanding (Basic) | 91 | 88 | 43 | 41 | 31 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 91 | 88 | 43 | 41 | 31 | 7 | Upgrade
|
| Shares Change (YoY) | 20.10% | 104.14% | 4.78% | 32.72% | 322.85% | 242.22% | Upgrade
|
| EPS (Basic) | -1.26 | -1.33 | -3.31 | -1.70 | -2.00 | -5.01 | Upgrade
|
| EPS (Diluted) | -1.26 | -1.33 | -3.31 | -1.70 | -2.00 | -5.01 | Upgrade
|
| Free Cash Flow | -100.36 | -93.5 | -98.18 | -61.55 | -64.1 | -42.54 | Upgrade
|
| Free Cash Flow Per Share | -1.10 | -1.06 | -2.28 | -1.50 | -2.07 | -5.81 | Upgrade
|
| Gross Margin | - | - | - | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | - | - | - | -290.32% | -619.15% | -177.01% | Upgrade
|
| Profit Margin | - | - | - | -279.27% | -637.19% | -204.87% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -246.29% | -658.77% | -237.63% | Upgrade
|
| EBITDA | -114.44 | -121.15 | -126.48 | -69.98 | -58.71 | -30.47 | Upgrade
|
| EBITDA Margin | - | - | - | -280.02% | - | -170.17% | Upgrade
|
| D&A For EBITDA | 6.53 | 6.47 | 6.1 | 2.58 | 1.54 | 1.23 | Upgrade
|
| EBIT | -120.97 | -127.62 | -132.58 | -72.55 | -60.24 | -31.69 | Upgrade
|
| EBIT Margin | - | - | - | -290.32% | - | -177.01% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.